Cipla Ltd Share Price – NSE  / BSE

Pharmaceuticals, Mid Cap

Cipla Ltd rose for a fifth straight session today. The stock is quoting at Rs 1493.85, up 1.46% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is down around 0.98% on the day, quoting at 23962.25. The Sensex is at 79274.83, down 1.13%. Cipla Ltd has added around 1.93% in last one month.

Meanwhile, Nifty Pharma index of which Cipla Ltd is a constituent, has added around 3.99% in last one month and is currently quoting at 22314.55, up 1.32% on the day. The volume in the stock stood at 20.09 lakh shares today, compared to the daily average of 26.41 lakh shares in last one month.

The benchmark December futures contract for the stock is quoting at Rs 1501.95, up 1.99% on the day. Cipla Ltd is up 20.84% in last one year as compared to a 13.3% gain in NIFTY and a 40.24% gain in the Nifty Pharma index.

The PE of the stock is 28.08 based on TTM earnings ending September 24.

Powered by Capital Market - Live News

Cipla said it has received the nod from Central Drugs Standard Control Organisation (CDSCO) for the exclusive distribution and marketing of Afrezza - inhalation human insulin in India.

Greaves Cotton board approved OFS of certain shares of arm Greaves Electric held by the company in the proposed IPO.

PC Jeweller to issue 5.2 crore equity shares to consortium lenders at an issue price of Rs 292 each.

Shriram Finance completed the sale of entire 84.4% stake in arm Shriram Housing Finance to Warburg Pincus for Rs 3,929 crore.

Grasim Industries board approved a fund raise of up to Rs 2,000 crore via NCDs on a private placement basis.

Gland Pharma received a US FDA approval for Phytonadione Injectable Emulsion. The product is indicated in coagulation disorders caused by Vitamin K deficiency.

Ami Organics approved enhancement in capital expenditure of Rs 177 crore for its brownfield project of electrolytes additives products at Jnagadia facility in Gujarat.

Reliance Power arm won a 930 MW solar energy contract with battery energy storage system project (BESS) from Solar Energy Corporation of India (SECI) in a reverse e-auction.

Sammaan Capital board approved a fundraising plan of up to Rs 2,500 crore via qualified institutional placement.

Godawari Power & Ispat has entered into an agreement with GAIL for supply of RLNG Gas for the company's upcoming pellet plant in the ordinary course of business for a period of 7 years.

Powered by Capital Market - Live News

Cipla Ltd is down for a fifth straight session today. The stock is quoting at Rs 1456.05, down 0.88% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is down around 0.35% on the day, quoting at 24533.8. The Sensex is at 81280.68, down 0.28%.Cipla Ltd has lost around 6.23% in last one month.Meanwhile, Nifty Pharma index of which Cipla Ltd is a constituent, has eased around 0.66% in last one month and is currently quoting at 22309.1, down 0.5% on the day. The volume in the stock stood at 17.34 lakh shares today, compared to the daily average of 23.86 lakh shares in last one month.

The benchmark December futures contract for the stock is quoting at Rs 1462.05, down 0.81% on the day. Cipla Ltd jumped 21.11% in last one year as compared to a 16.84% rally in NIFTY and a 38.38% spurt in the Nifty Pharma index.

The PE of the stock is 28.03 based on TTM earnings ending September 24.

Powered by Capital Market - Live News

Cipla Ltd fell for a fifth straight session today. The stock is quoting at Rs 1478.6, down 1.41% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is down around 0.34% on the day, quoting at 23452.35. The Sensex is at 77362.6, down 0.28%.Cipla Ltd has eased around 2.96% in last one month.Meanwhile, Nifty Pharma index of which Cipla Ltd is a constituent, has eased around 6.32% in last one month and is currently quoting at 21752, down 0.42% on the day. The volume in the stock stood at 10.32 lakh shares today, compared to the daily average of 28.45 lakh shares in last one month.

The benchmark November futures contract for the stock is quoting at Rs 1481.85, down 1.3% on the day. Cipla Ltd jumped 18.56% in last one year as compared to a 19.08% rally in NIFTY and a 37.04% spurt in the Nifty Pharma index.

The PE of the stock is 28.61 based on TTM earnings ending September 24.

Powered by Capital Market - Live News